Researchers from Duke University predict that millions more Americans may soon be prescribed statins to lower their cholesterol in light of recent guidelines that recommend drugs similar to one pending Lipitor lawsuit litigation.
CNN.com reported Wednesday on the findings of a new study that suggests 13 more million Americans between the ages of 40 and 75 years old may soon be given statins to reduce the risk of strokes and heart disease. According to the article on April 15th, a total of 56 million people in the U.S. would be eligible for statins on new guidelines from the American Heart Association and the American College of Cardiology. Research looks at the heart disease risk factors of 3,773 people who participated in the National Health and Nutrition Examination Survey (NHANES) between 2005 and 2010, and found that 10.4 million individuals fit the new criteria.
Under old guidelines, which were based on an individual’s level of cholesterol in the blood stream, as well as family history, smoking, hypertension and other factors, 43.2 million people were eligible to receive statins. New rules, however, suggest statin use in people whose risk for developing heart disease in the next 10 years is 7.5% higher. The American Heart Association also relies on age, weight and smoking history in its assessment of a healthy person’s risk for developing heart issues, according to CNN.com.
Less than two weeks before this article was published, a study published in the Journal of the American Medical Association indicates that the majority of men in Europe would be recommended Lipitor and other statins if guidelines go into effect there. According to research published on April 9th, 96.4% of men and 65.8% of women with a mean age of 65.5 could be prescribed the medications if that were to happen. Authors of this study reached their conclusions after applying data from 4,854 patients included in a European study that was conducted from 1997 to 2001.
One may wonder how the American College of Cardiology and the American Heart Association’s recent recommendation will affect a Lipitor lawsuit litigation now pending in South Carolina federal court. Included in the federal proceeding now underway in the U.S. District Court, District of South Carolina are hundreds of claims that allege new-onset Type 2 diabetes caused by the statin.
Contact our Firm today to learn more about Lipitor lawsuits, and whether you may be eligible to file a claim over the cholesterol-lowering statin. Call us now at .